{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:24Z","timestamp":1707524604696},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,31]]},"DOI":"10.7759\/cureus.23688","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:15:38Z","timestamp":1648743338000},"source":"Crossref","is-referenced-by-count":0,"title":["Post-transplant Complication With TAFRO Features in a Patient With Acute Myeloid Leukemia"],"prefix":"10.7759","author":[{"given":"Kyosuke","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Katsuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly (Article in Japanese)","volume":"51","author":"Takai K","year":"2010","unstructured":"Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly (Article in Japanese). Rinsho Ketsueki. 2010, 51:320-5.","journal-title":"Rinsho Ketsueki"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-1979-1","article-title":"Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version","volume":"103","author":"Masaki Y","year":"2016","unstructured":"Masaki Y, Kawabata H, Takai K, et al.. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016, 103:686-92. 10.1007\/s12185-016-1979-1","journal-title":"Int J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26292","article-title":"Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease","volume":"96","author":"Nishimura Y","year":"2021","unstructured":"Nishimura Y, Fajgenbaum DC, Pierson SK, et al.. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. Am J Hematol. 2021, 96:1241-52. 10.1002\/ajh.26292","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia MH","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, et al.. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015, 21:389-401.e1. 10.1016\/j.bbmt.2014.12.001","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02780-1","article-title":"2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome","volume":"111","author":"Masaki Y","year":"2020","unstructured":"Masaki Y, Kawabata H, Takai K, et al.. 2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol. 2020, 111:155-8. 10.1007\/s12185-019-02780-1","journal-title":"Int J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2015.1120389","article-title":"TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review","volume":"28","author":"Sakai K","year":"2018","unstructured":"Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Ueda Y. TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review. Mod Rheumatol. 2018, 28:564-9. 10.3109\/14397595.2015.1120389","journal-title":"Mod Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.236.289","article-title":"Successful treatment of TAFRO syndrome, a variant of multicentric Castleman's disease, with cyclosporine A: possible pathogenetic contribution of interleukin-2","volume":"236","author":"Konishi Y","year":"2015","unstructured":"Konishi Y, Takahashi S, Nishi K, et al.. Successful treatment of TAFRO syndrome, a variant of multicentric Castleman's disease, with cyclosporine A: possible pathogenetic contribution of interleukin-2. Tohoku J Exp Med. 2015, 236:289-95. 10.1620\/tjem.236.289","journal-title":"Tohoku J Exp Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/24725625.2020.1789304","article-title":"Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab","volume":"5","author":"Wakiya R","year":"2021","unstructured":"Wakiya R, Kameda T, Takeuchi Y, et al.. Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab. Mod Rheumatol Case Rep. 2021, 5:145-51. 10.1080\/24725625.2020.1789304","journal-title":"Mod Rheumatol Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka T","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014, 6:a016295. 10.1101\/cshperspect.a016295","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.03.006","article-title":"A case of cerebral infarction in a patient with TAFRO syndrome","volume":"400","author":"Goda T","year":"2019","unstructured":"Goda T, Oyama N, Iwamoto T, et al.. A case of cerebral infarction in a patient with TAFRO syndrome. J Neurol Sci. 2019, 400:21-2. 10.1016\/j.jns.2019.03.006","journal-title":"J Neurol Sci"},{"key":"ref11","article-title":"IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation","volume":"83","author":"Ferr\u00e0 C","year":"1998","unstructured":"Ferr\u00e0 C, de Sanjos\u00e9 S, Gallardo D, et al.. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation. Haematologica. 1998, 83:1082-7.","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703272","article-title":"Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantation","volume":"28","author":"Tegg EM","year":"2001","unstructured":"Tegg EM, Griffiths AE, Lowenthal RM, et al.. Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantation. Bone Marrow Transplant. 2001, 28:929-33. 10.1038\/sj.bmt.1703272","journal-title":"Bone Marrow Transplant"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease","volume":"114","author":"Chen X","year":"2009","unstructured":"Chen X, Das R, Komorowski R, Beres A, Hessner MJ, Mihara M, Drobyski WR. Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood. 2009, 114:891-900. 10.1182\/blood-2009-01-197178","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/92137-post-transplant-complication-with-tafro-features-in-a-patient-with-acute-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:18Z","timestamp":1707507378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/92137-post-transplant-complication-with-tafro-features-in-a-patient-with-acute-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.23688","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,31]]}}}